Celgene IM: Pancreatic Cancer Advisory Board – ASCO 2019


Kstorfin Medical Communications

Celgene-logo-P280

Pancreatic Cancer Advisory Board Meeting

06:00 AM – 08:00 AM, Monday 3 June 2019

Venue TBC, Chicago, IL, USA

 

Meeting objectives:

• To gain a better understanding of the perception and use of nab-paclitaxel + gemcitabine in metastatic pancreatic cancer across a wide range of countries
• To gain feedback on the current evidence base supporting nab-paclitaxel + gemcitabine in metastatic pancreatic cancer and earlier disease
• To identify country-/region-specific endorsements and/or barriers to the use of nab-paclitaxel + gemcitabine in pancreatic cancer (e.g. treatment guidelines, reimbursement policies)

 

This meeting is organised by the Celgene International Markets team and is intended for delegates already attending ASCO. As such, no assistance with travel or accommodation is offered.

* = required field

This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
Required. Please check email is formatted correctly
This field is required
This field is required
This field is required
Required. Please check email is formatted correctly
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
Please ensure you have entered the correct information into each required field

You can save your progress so far and come back to it later.

You can now safely leave the registration form. When you come back, the information you have entered will still be here.

SAVE FOR LATER CONTINUE